Cargando…

Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis

PURPOSE: We designed a phase I/II trial of intraperitoneal (IP) docetaxel plus S-1 to determine the maximum tolerated dose (MTD) and recommended dose (RD) and to evaluate its efficacy and safety in gastric cancer patients with peritoneal carcinomatosis (PC). METHODS: Patients with PC confirmed by la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fushida, S., Kinoshita, J., Kaji, M., Hirono, Y., Goda, F., Yagi, Y., Oyama, K., Sudo, Y., Watanabe, Y., Fujimura, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636429/ https://www.ncbi.nlm.nih.gov/pubmed/23423490 http://dx.doi.org/10.1007/s00280-013-2122-0

Ejemplares similares

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial
por: Fushida, Sachio, et al.
Publicado: (2016)

Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
por: Kinoshita, Jun, et al.
Publicado: (2014)

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies
por: Wu, Hai-Tao, et al.
Publicado: (2016)

INTRAPERITONEAL CHEMOTHERAPY FOR GASTRIC CANCER WITH PERITONEAL CARCINOMATOSIS: STUDY PROTOCOL OF A PHASE II TRIAL
por: Ramos, Marcus Fernando Kodama Pertille, et al.
Publicado: (2023)

Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer
por: Fushida, Sachio, et al.
Publicado: (2015)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017)

Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats
por: Otto, Jens, et al.
Publicado: (2007)

Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
por: Kondo, A., et al.
Publicado: (1996)

The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer
por: TSUKADA, TOMOYA, et al.
Publicado: (2012)

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study
por: Tang, Li, et al.
Publicado: (2011)

Arandomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease
por: Fushida, Sachio, et al.
Publicado: (2015)

A randomized controlled trial of postoperative intravenous acetaminophen plus thoracic epidural analgesia vs. thoracic epidural analgesia alone after gastrectomy for gastric cancer
por: Kinoshita, Jun, et al.
Publicado: (2018)

A case of disseminated carcinomatosis of the bone marrow originating from gastric cancer 3 years after intraperitoneal chemotherapy against peritoneal carcinomatosis
por: Okuno, Takayuki, et al.
Publicado: (2016)

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly
por: Huang, Yeqian, et al.
Publicado: (2015)

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody
por: Fushida, Sachio, et al.
Publicado: (2013)

Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy – PIPAC-OPC2
por: Graversen, Martin, et al.
Publicado: (2018)

Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab
por: Goéré, Diane, et al.
Publicado: (2014)

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
por: Solaini, Leonardo, et al.
Publicado: (2019)

Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial
por: Senthil, Maheswari, et al.
Publicado: (2023)

Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy
por: Kim, Sungho, et al.
Publicado: (2022)

Phase II Trial of Preoperative Chemotherapy with Docetaxel, Cisplatin and S-1 for T4 Locally Advanced Gastric Cancer
por: Fushida, Sachio, et al.
Publicado: (2012)

Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
por: Hirono, Y., et al.
Publicado: (1996)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis
por: Nowacki, Maciej, et al.
Publicado: (2017)

Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations
por: Pelz, Joerg OW, et al.
Publicado: (2006)

Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
por: Canda, Aras Emre, et al.
Publicado: (2018)

Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study
por: Somashekhar, S. P., et al.
Publicado: (2019)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
por: Roh, Seung Jae, et al.
Publicado: (2020)

Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
por: García-Olmo, D., et al.
Publicado: (2021)

The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Gastric peritoneal carcinomatosis - a retrospective review
por: Tan, Hwee Leong, et al.
Publicado: (2017)

Gastric Cancer Peritoneal Carcinomatosis Risk Score
por: Ji, Liang, et al.
Publicado: (2019)

Laparoscopic Heated Intraperitoneal Chemotherapy in the Treatment of Carcinomatosis of Gastric Adenocarcinoma Origin
por: White, Michael G., et al.
Publicado: (2021)

Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
por: Yu, Hsin-Hsien, et al.
Publicado: (2023)

Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives?
por: Cortes-Guiral, Delia, et al.
Publicado: (2017)

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer: A Phase II Study from a Chinese Center
por: Huang, Chao-Qun, et al.
Publicado: (2014)

Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Rodt, Anne Peen, et al.
Publicado: (2013)

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
por: Vassos, Nikolaos, et al.
Publicado: (2016)

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Hübner, Martin, et al.
Publicado: (2017)

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer
por: Lee, Seung Joon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_200t9oabogig41bq8gkdakai65